Jupiter Research Capital (Asia) Ltd’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
Other funds holding GH
Jupiter Research Capital (Asia) Ltd's GH Position: Q3 2026 in Review
Jupiter Research Capital (Asia) Ltd reduced its Guardant Health (GH) stake by 88% in Q3 2026, selling an estimated $4.37M and leaving 3,598 shares worth $642K. The position accounts for 0.07% of the portfolio, ranked #303.
Jupiter Research Capital (Asia) Ltd first reported a position in GH in Q4 2025 and has held it in 3 quarters since. The position peaked at $4.55M in Q2 2026. 621 funds tracked by Wall St. Rank hold GH as of Q3 2026.
- Jupiter Research Capital (Asia) Ltd held 3,598 shares of Guardant Health worth $642K as of Q3 2026.
- Jupiter Research Capital (Asia) Ltd sold 26,731 Guardant Health shares in Q3 2026, an estimated $4.37M.
- Guardant Health made up 0.07% of Jupiter Research Capital (Asia) Ltd's portfolio in Q3 2026, its #303 holding.
- Jupiter Research Capital (Asia) Ltd first reported a position in Guardant Health in Q4 2025 and has held it in 3 quarters since.
- Jupiter Research Capital (Asia) Ltd's Guardant Health position peaked at $4.55M in Q2 2026.
- 621 funds tracked by Wall St. Rank held Guardant Health as of Q3 2026.
Based on Jupiter Research Capital (Asia) Ltd's 13F filing for Q3 2026, filed 16 Nov 2026.